drugset
drugset / Trial / NCT04021563

The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers

NCT04021563 ↗

Phase 1 Completed 64 enrolled Shanghai SIMR Biotechnology Co., Ltd. Syneos Health · collab
RandomizedSequentialDouble-blindTreatment

Summary

This study is to evaluate the safety, tolerability, PK of SR419 in healthy volunteers.

Timeline

Start
2019-07-26
Primary completion
2019-12-10
Completion
2019-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject SR419 Unknown — Oral

Indications

No indication recorded.